Impact of the COVID-19 pandemic on inflammatory bowel disease patients:A review of the current evidence

作     者：Marko Kumric Tina Ticinovic Kurir Dinko Martinovic Piero Marin Zivkovic Josko Bozic 

作者机构：Department of PathophysiologyUniversity of Split School of MedicineSplit 21000Croatia Department of EndocrinologyUniversity Hospital of SplitSplit 21000Croatia Department of GastroenterologyUniversity Hospital of SplitSplit 21000Croatia 

出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)

年 卷 期：2021年第27卷第25期

页      面：3748-3761页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：COVID-19 SARS-CoV-2 Inflammatory bowel disease Crohn’s disease Ulcerative colitis 

摘      要：Since the initial coronavirus disease 2019(COVID-19)outbreak in China in December 2019,the infection has now become the biggest medical issue of modern *** major contributors that amplified the impact of the disease and subsequently increased the burden on health care systems were high mortality among patients with multiple co-morbidities and overcapacity of intensive care *** the gastroenterology-related community,particular concern was raised with respect to patients with inflammatory bowel disease(IBD),as those patients are prone to opportunistic infections mainly owing to their immunosuppressive-based ***,we sought to summarize current knowledge regarding COVID-19 infection in patients with ***,it seems that IBD is not a comorbidity that poses an increased risk for COVID-19 acquisition,except in patients treated with ***,outcomes of the infected patients are largely dependent on therapeutic modality by which they are treated,as some worsen the clinical course of COVID-19 infection,whereas others seem to dampen the detrimental effects of ***,we discussed the present and the future impact of COVID-19 pandemic and concomitantly increased health care burden on IBD-management.